Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study
Top Cited Papers
- 1 September 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 390 (10102), 1603-1610
- https://doi.org/10.1016/s0140-6736(17)31449-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Comparison of the cobas 4800 CT/NG Test with Culture for Detecting Neisseria gonorrhoeae in Genital and Nongenital Specimens in a Low-Prevalence Population in New ZealandJournal of Clinical Microbiology, 2013
- Effectiveness of a vaccination programme for an epidemic of meningococcal B in New ZealandVaccine, 2011
- Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlersArchives of Disease in Childhood, 2011
- Chlamydial Infection Increases Gonococcal Colonization in a Novel Murine Coinfection ModelInfection and Immunity, 2011
- Vaccines for Gonorrhea: Can We Rise to the Challenge?Frontiers in Microbiology, 2011
- Pathogenic neisseriae: surface modulation, pathogenesis and infection controlNature Reviews Microbiology, 2009
- Influence of Study Population on the Identification of Risk Factors for Sexually Transmitted Diseases using a Case-Control Design: The Example of GonorrheaAmerican Journal of Epidemiology, 2004
- Gonorrhoea reinfection in heterosexual STD clinic attendees: longitudinal analysis of risks for first reinfectionSexually Transmitted Infections, 2003
- NadA, a Novel Vaccine Candidate of Neisseria meningitidis The Journal of Experimental Medicine, 2002
- THE TREATMENT OF GONOCOCCUS INFECTIONS BY VACCINES.The Lancet, 1909